Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues
Funding
Conflicts of Interest
References
- Pagano, G.; Pallardó, F.V.; Porto, B.; Fittipaldi, M.R.; Lyakhovich, A.; Trifuoggi, M. Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction. Antioxidants 2020, 9, 82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodríguez, L.R.; Lapeña, T.; Calap-Quintana, P.; Moltó, M.D.; Gonzalez-Cabo, P.; Navarro Langa, J.A. Antioxidant Therapies and Oxidative Stress in Friedreich’s Ataxia: The Right Path or Just a Diversion? Antioxidants 2020, 9, 664. [Google Scholar] [CrossRef] [PubMed]
- Seco-Cervera, M.; González-Cabo, P.; Pallardó, F.V.; Romá-Mateo, C.; García-Giménez, J.L. Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia. Antioxidants 2020, 9, 1257. [Google Scholar] [CrossRef] [PubMed]
- Bono-Yagüe, J.; Gómez-Escribano, A.P.; Millán, J.M.; Vázquez-Manrique, R.P. Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch? Antioxidants 2020, 9, 577. [Google Scholar] [CrossRef] [PubMed]
- Domènech, B.E.; Marfany, G. The Relevance of Oxidative Stress in the Pathogenesis and Therapy of Retinal Dystrophies. Antioxidants 2020, 9, 347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Espinós, C.; Galindo, M.I.; García-Gimeno, M.A.; Ibáñez-Cabellos, J.S.; Martínez-Rubio, D.; Millán, J.M.; Rodrigo, R.; Sanz, P.; Seco-Cervera, M.; Sevilla, T.; et al. Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration. Antioxidants 2020, 9, 313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Romá-Mateo, C.; García-Giménez, J.L. Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues. Antioxidants 2021, 10, 617. https://doi.org/10.3390/antiox10040617
Romá-Mateo C, García-Giménez JL. Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues. Antioxidants. 2021; 10(4):617. https://doi.org/10.3390/antiox10040617
Chicago/Turabian StyleRomá-Mateo, Carlos, and José Luis García-Giménez. 2021. "Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues" Antioxidants 10, no. 4: 617. https://doi.org/10.3390/antiox10040617
APA StyleRomá-Mateo, C., & García-Giménez, J. L. (2021). Oxidative Stress and Rare Diseases: From Molecular Crossroads to Therapeutic Avenues. Antioxidants, 10(4), 617. https://doi.org/10.3390/antiox10040617